Consensus Watch on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)

In the most recent trading session, Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) shares saw a move of +0.00%. Covering Wall Street analysts have a consensus target price of $9.33 on the stock. Target predictions might differ vastly from analyst to analyst. This target is applying estimates from analysts polled by Thomson Reuters. 

In order to arrive at a price target, analysts and investors alike use various metrics to determine where the stock might be headed. One of the most common is the Price to Earnings Ratio or P/E Ratio. This is calculated by taking the current share price and dividing it by the forecasted earnings per share. As of writing, Ohr Pharmaceuticals, Inc. has a price to earnings ratio of N/A. Taking a step further, investors can also look to a firm’s price to earnings growth or PEG ratio. The PEG ratio represents the ratio of the price to earnings to the expected future growth rate of the company. A company with a PEG ratio greater than one might be considered overvalued using this metric alone. On the other hand if a firm has a PEG below one could be considered undervalued. A PEG that is close to one, is often considered fair value. The stock has a current PEG of -0.03.

Some other technicals to consider would be the moving averages of the company. In comparing the current price level of the equity to their moving averages, the shares are trading $-0.13 off of the 50-day average of $3.03 and $0.05 away from the 200-day moving average of $2.85.

Another important factor to consider when evaluating a stock’s current and future value are the 52 week high and low levels. As of the most recent bid at the time of writing, Ohr Pharmaceuticals, Inc. shares are trading -55.79% away from the 52-week high mark of 6.56 and +18.85% off the 52-week bottom of 2.44.